Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flexion Therapeutics Inc (NASDAQ:FLXN)

13.93
Delayed Data
As of Jun 24
 -0.91 / -6.13%
Today’s Change
7.56
Today|||52-Week Range
29.09
-27.71%
Year-to-Date
Brexit Bargains: 3 Clinical-Stage Biotechs to Buy
Jun 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close14.84
Today’s open14.30
Day’s range13.84 - 14.84
Volume1,049,290
Average volume (3 months)402,868
Market cap$377.1M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-9.14%
Earnings growth (this year)-44.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.89

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...-0.10-4.76%
SGMOSangamo BioSciences ...-0.41-6.93%
ARWRArrowhead Pharmaceut...-0.41-6.97%
AMRIAlbany Molecular Res...-0.48-3.43%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$0.00
Annual profit (last year)-$46.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael D. Clayman
Chief Financial Officer
Frederick W. Driscoll
Corporate headquarters
Burlington, Massachusetts

Forecasts

Partner Offers

Search for Jobs